VC firms
Aescap Life Sciences investeert in snel groeiende beursgenoteerde biotech bedrijven die innovatieve medicijnen ontwikkelen en commercialiseren.
Overview
Employees
1-10
Persons 2
| Date | First Name | Last Name | Title | Location | |||
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Alba | Montoro | Analyst |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 25, 2007 | Aquapharm Biodiscovery nets $8.3M for marine-based antibiotics | Aquapharm Biodiscovery, a Scottish biotech aiming to discover new antibiotics and antioxidants from marine organisms, raised $8.3 million (£4 million) in a second funding round (PDF). The company, based near Oban in the European Center for ... |
Reviews 0
FAQ about Aescap
What has the press written about Aescap?
Parsers VC has collected 2 articles mentioning Aescap, among them “Aquapharm Biodiscovery nets $8.3M for marine-based antibiotics” (Jul 25, 2007).
Is Aescap still active?
Yes, Aescap is active; its latest activity on Parsers VC dates from Jul 10, 2026.